{
  "docId": "019de071-25c2-72af-a047-b47d3e86c276",
  "docSlug": "cf4915d9030a007285d7f2ca06f3bce1",
  "documentTitle": "Graphite Bio | IPO Presentation Deck | 50 slides",
  "authorId": "graphite-bio",
  "authorName": "Graphite Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 50,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a three-column structure to explain the biological basis, clinical proof-of-concept, and the company's specific therapeutic approach.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-25c2-72af-a047-b47d3e86c276/22",
  "deckHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276",
  "deckJsonHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276.json",
  "deckAnchorHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.1,
        "x": 0.55,
        "y": 0.3
      },
      "kind": "image",
      "text": "Human body silhouette with organ icons",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ae2efa4-0810-4b63-b538-5949e867164a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.25,
        "x": 0.35,
        "y": 0.2
      },
      "kind": "list",
      "text": "POC for dozens of genetic diseases via allogeneic HSC transplant (HSCT): Sickle Cell, SCID-X1, Gaucher, MPS, Beta Thalassemia, PNH, Krabbe",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3545a302-26fd-49b3-ae95-f2603a57569f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.25,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Hematopoietic Stem Cell (HSC) Multi-potent: differentiate into multiple blood and immune cell lineages Permanent: can reconstitute blood and immune system for a lifetime",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44ac16db-88fd-4821-af41-e864f4bf4054",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.25,
        "x": 0.7,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Realizing HSCs' full therapeutic potential. Engineering autologous HSCs: Matched, no GVHD, Potentially permanent production of virtually any protein. Applying non-genotoxic HSC targeted conditioning: May significantly expand eligible populations",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "73235150-5235-4bd6-8f1d-2d7c1fe04895",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. Orphanet. 2. Center for international blood and marrow transplant research.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3777d785-c78e-49d4-b2ca-a748411c11cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Initial focus on engineering autologous hematopoietic stem cells for potentially curative treatments",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31a12d08-6a81-4d23-929f-f012723a1ee5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "548f982b-b53d-45e8-8a2e-2ee16c994995",
      "evidence": "list/bullet: POC for dozens of genetic diseases via allogeneic HSC transplant (HSCT): Sickle Cell, SCID-X1, Gaucher, MPS, Beta Thalassemia, PNH, Krabbe",
      "confidence": 0.5
    },
    {
      "name": "Storytelling: audience calibration",
      "slug": "audience",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "1ba0bb23-f2dd-4f10-98a9-a33b6bdf7f63",
      "evidence": "paragraph/paragraph: Realizing HSCs' full therapeutic potential.",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}